TLSA · Tiziana Life Sciences Ltd
United States · RS rating 11 · As of 2026-11-03
| Price | 0.69 USD |
|---|---|
| 1-day change | +3.0% |
| RS rating (overall / 1M / 3M / 12M) | 11 / 9 / 21 / 15 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 15 / 5 / 17 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +62.9% |
| Market cap (USD) | $156.5M |